Food Allergies, Managing HAE Top ACAAI Agenda – MedPage Today


MedPage Today

Food Allergies, Managing HAE Top ACAAI Agenda
MedPage Today
One step in that direction is the release of an international consensus report on hereditary angioedema (HAE) and similar acquired conditions, developed by the ACAAI and several other organizations including the American Academy of Allergy, Asthma, and
Physicians can Stage an "Allergy Intervention" to Discuss Relief of Symptoms MarketWatch (press release)
Report Aims to Prevent Medical Misdiagnoses and Under TreatmentNewswise (press release)

all 4 news articles »

View full post on asthma – Google News

Asthma Worsens with Step-Off Therapy – MedPage Today

Asthma Worsens with Step-Off Therapy
MedPage Today
Discontinuation of long-acting beta-agonist therapy in patients whose asthma is well controlled is associated with a worsening of symptom control and quality of life, a systematic review suggested. Withdrawing a long-acting beta-agonist resulted in a 0
Stopping Controversial Asthma Drugs Could Have Downside: StudyU.S. News & World Report
Study Questions Recommendation to Discontinue LABA Therapy in Asthma Science Daily (press release)

all 6 news articles »

View full post on asthma – Google News

Monoclonal Antibody Works in Severe Asthma – MedPage Today


Examiner.com

Monoclonal Antibody Works in Severe Asthma
MedPage Today
Note that a multicenter, randomized placebo-controlled trial found that mepolizumab, a monoclonal antibody against interleukin-5, decreased asthma exacerbations, hospitalizations, and emergency department visits for patients with severe asthma and
Clinical study: New asthma drug cuts attack frequency in halfExaminer.com
GSK severe asthma drug progresses to Phase IIIInPharm
GSK asthma drug cuts symptoms 52%; ready for PhIIIPharma Times
Business Recorder (blog) –World First Travel Insurance –The Inquisitr
all 8 news articles »

View full post on asthma – Google News

FDA Greenlights Asthma Drug Generics – MedPage Today


MedPage Today

FDA Greenlights Asthma Drug Generics
MedPage Today
SILVER SPRING, Md. — Generic forms of the popular asthma drug montelukast sodium (Singulair) produced by 10 manufacturers have won FDA approval, the agency announced. Montelukast is a leukotriene receptor antagonist and, unlike other most other
FDA approves generic versions of SingulairNBCNews.com
FDA approves first generic versions of Singulair to treat asthma, allergiesFDA.gov
First Generic Versions of Singulair ApprovedU.S. News & World Report

all 18 news articles »

View full post on asthma – Google News